-
-
Actonel is a popular brand of Risedronate which is a bisphosphonate drug used to treat and prevent bone resorption. It's applications include Osteoporosis, generally strengthening bone, and treating Paget's disease of bone.
-
Fast Facts:
- Taken orally
- If lodged in the esophagus can cause esophageal ulcers
- Usual dosage: 5 mg daily or 35 mg weekly
- Take with a full glass of waterWebMD: Actonel
- Take when standing upright, to help movement into the stomachWebMD: Actonel
- Take at least two hours after and thirty minutes before mealsWebMD: Actonel
- Can cause osteonecrosis of the jaw in very rare casesPubMed: Bisphosphonates and osteonecrosis of the jaws
Cautions
Actonel can cause ulcers in the esophagus if it does not reach the stomach, so it must be taken carefully; additionally, because it is not absorbed well when food is present in the stomach, it has to be taken when the stomach is relatively empty. Finally, Actonel can cause jaw necrosis, similar to the 'phossy jaw' that results from toxic phosphorus exposure. Disclaimer: The content in this page is not a substitute for professional medical advice. Please contact your doctor before taking Actonel (Risedronate).
-
-
Actonel (Risedronate) on Amazon
-
Weekly risedronate shown as effective as daily dose regimen: first study of its kind.(Clinical Rounds): An article from: Internal Medicine News - $5.95
This digital document is an article from Internal Medicine News, published by International Medical News Group on September 1, 2003. The length of the article is 2040 words. The pa...Amazon
-
Risedronate gains approval for male osteoporosis.(Endocrinology)(Clinical report): An article from: Internal Medicine News - $9.95
This digital document is an article from Internal Medicine News, published by Thomson Gale on September 15, 2006. The length of the article is 1059 words. The page length shown abo...Amazon
-
Alendronate edged risedronate in BMD trial, but some skeptical.(Musculoskeletal Disorders)(bone mineral density): An article from: Family Practice News - $5.95
This digital document is an article from Family Practice News, published by International Medical News Group on February 1, 2005. The length of the article is 452 words. The page l...Amazon
-
A Once-weekly Formulation of Risedronate Sodium Hydrate, an Antiosteoporotic Agent, Was Approved.: An article from: JCN Newswires - $9.95
This digital document is an article from JCN Newswires, published by Thomson Gale on April 18, 2007. The length of the article is 568 words. The page length shown above is based on...Amazon
-
Alendronate beats risedronate in increasing BMD.(Gynecology): An article from: OB GYN News - $5.95
This digital document is an article from OB GYN News, published by Thomson Gale on March 1, 2006. The length of the article is 603 words. The page length shown above is based on a ...Amazon
-
About this page
-
Page Views0
